Why is Valiant Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Operating Profit of 461.7%, the company declared Very Positive results in Sep 26
- The company has declared positive results for the last 3 consecutive quarters
- PAT(Latest six months) Higher at Rs 21.51 cr
- ROCE(HY) Highest at 7.74%
- NET SALES(Q) Highest at Rs 116.77 cr
3
Stock is technically in a Mildly Bullish range
- The stocks Bollinger Band and DOW technical factors are also Mildly Bullish
4
With ROE of 4.9, it has a Attractive valuation with a 1.6 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 28.50%, its profits have risen by 219.7% ; the PEG ratio of the company is 0.2
5
Market Beating Performance
- The stock has generated a return of 28.50% in the last 1 year, much higher than market (BSE500) returns of 0.37%
How much should you buy?
- Overall Portfolio exposure to Valiant Laborato should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Valiant Laborato for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Valiant Laborato
28.5%
0.49
57.77%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
11.49%
EBIT Growth (5y)
11.87%
EBIT to Interest (avg)
2.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.73
Tax Ratio
34.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
0.65%
ROE (avg)
2.16%
Valuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
40
Price to Book Value
1.62
EV to EBIT
20.10
EV to EBITDA
14.07
EV to Capital Employed
1.62
EV to Sales
1.43
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
8.06%
ROE (Latest)
4.88%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
26What is working for the Company
PAT(Latest six months)
Higher at Rs 21.51 cr
ROCE(HY)
Highest at 7.74%
NET SALES(Q)
Highest at Rs 116.77 cr
-6What is not working for the Company
PBT LESS OI(Q)
At Rs 0.56 cr has Fallen at -89.8% (vs previous 4Q average
PAT(Q)
At Rs 0.41 cr has Fallen at -89.8% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Valiant Laborato
Net Sales - Quarterly
Highest at Rs 116.77 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 116.77 cr has Grown at 52.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 76.48 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Valiant Laborato
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 0.56 cr has Fallen at -89.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 5.50 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 0.41 cr has Fallen at -89.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 4.00 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)